Rotavirus vaccines in Belgium: Policy and impact

Pediatric Infectious Disease Journal

Volumn 30, Issue SUPPL. 1, 2011, Pages

  Braeckman, Tessa ^a   Van Herck, Koen ^a,b   Raes, Marc ^c   Vergison, Anne ^d   Sabbe, Martine ^e   Van Damme, Pierre ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c JESSA HOSPITAL   (Belgium)

^d HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^e SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

Author keywords

burden of disease; impact; rotavirus; vaccination

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; BELGIUM; CHILD; CHILD HOSPITALIZATION; CLINICAL EFFECTIVENESS; HEALTH CARE POLICY; HUMAN; MAJOR CLINICAL STUDY; MASS IMMUNIZATION; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; REIMBURSEMENT; RETROSPECTIVE STUDY; ROTAVIRUS INFECTION; VIRAL GASTROENTERITIS;

BELGIUM; CHILD, PRESCHOOL; GASTROENTERITIS; HEALTH POLICY; HOSPITALIZATION; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFANT, NEWBORN; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINATION;

EID: 78751490727     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181fefc51     Document Type: Article

References (24)

1. Black RE, Cousens S, Johnson HL, et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet. 2010;375: 1969-1987.
2. Parashar UD, Burton A, Lanata C, et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis. 2009;200(suppl 1):S9-S15.
3. Parashar UD, Hummelman EG, Bresee JS, et al. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis. 2003;9:565-572.
4. Glass RI, Bresee J, Jiang B, et al. Rotavirus and rotavirus vaccines. Adv Exp Med Biol. 2006;582:45-54.
5. Cortese MM, Parashar UD. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2009;58(RR-2): 1-25.
6. Giaquinto C, Damme PV. Age distribution of paediatric rotavirus gastroenteritis cases in Europe: the REVEAL study. Scand J Infect Dis. 2010;42: 142-147.
7. Soriano-Gabarro M, Mrukowicz J, Vesikari T, et al. Burden of rotavirus disease in European Union countries. Pediatr Infect Dis J. 2006;25(suppl 1):S7-S11.
8. Bilcke J, Van Damme P, De Smet F, et al. The health and economic burden of rotavirus disease in Belgium. Eur J Pediatr. 2008;167:1409-1419.
9. Bilcke JB, De Smet F, Hanquet G, et al. Cost-effectiveness analysis of rotavirus vaccination of Belgian infants. Health Technology Assessment (HTA). Brussels, Belgium: Belgian Health Care Knowledge Centre (KCE); 2007. KCE reports 54C:D2007/10.273/11.10
10. Bilcke J, Van Damme P, Beutels P. Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care" disease impact in Belgium. Med Decis Making. 2009;29:33-50.11
11. Goubau P, Hoppenbrouwers K, Levy J, et al. Vaccinatie van de zuigeling tegen gastro-enteritis veroorzaakt door het rotavirus. Advies Van De Hoge Gezondheidsraad; 2006. HGR file No. 8203.
12. Boonen M, Theeten H, Vandermeulen C, et al. Vaccinatiegraad bij jonge kinderen en adolescenten in Vlaanderen in 2008. Vlaams Infectieziektebul-letin. 2009;68:9-14.
13. Robert E, Swennen B. Enquete de couverture vaccinale des enfants de 18 à 24 mois en communaute francaise (Bruxelles excepte). Brussels, Belgium: PROVAC, School of Public Health ULB; November 2009.
14. Monitoring of Reimbursement Significant Expenses [in Dutch]. Semin Integr Rep 2008:1-32.Availableat: http://wwwrizivfgovbe/drug/nl/statistics-scientific- information/report/pdf/morse200801pdf. Accessed June 2010.
15. Ducoffre G, Hanquet G. Sentinel Laboratory Network (SLN): contribution to the national and international surveillance. In: Proceedings of the 20th Seminar on Diagnosis and Surveillance of Infectious Diseases; Brussels, Belgium, November 26, 2004.
16. Ducoffre G. Surveillance van Infectieuze Aandoeningen door een Netwerk van Laboratoria voor Microbiologie 2008. Epidemiologische Trends 1983-2007. Brussels, Belgium: SIPH; 2008. 2008;D/2009/2505/31.
17. Ducoffre G. Monthly reports of infectious diseases by a network of sentinel laboratories. SIPH. Available at: http://www.iph.fgov.be/epidemio/ epinl/plabnl/mens.htm. Accessed June 2010.
18. Raes M, Verjans MP, Mewis A. Rotavirus gastroenteritis after launching rotavirus vaccines: epidemiological data from a regional hospital in Belgium [abstract]. Nice, France: ESPID; 2010.
19. Strens DV, Standaert B. To investigate the effect of paediatric vaccination on rotavirus disease burden in Belgium [abstract]. Brussels, Belgium: ESPID; 2009.
20. Raes M, Strens D, Vergison A, et al. Second year post-rotavirus vaccination in Belgium: impact on rotavirus-positive samples in hospitalized children [abstract]. Nice, France: ESPID; 2010.
21. Matthijnssens J, Rahman M, Zeller M, et al. Rotavirus incidence and genotype fluctuations in the Gasthuisberg university hospital, three years after national rotavirus vaccine introduction in Belgium [abstract]. Nice, France: ESPID; 2010.
22. Tate JE, Panozzo CA, Payne DC, et al. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics. 2009;124:465-471.
23. Jit M, Edmunds WJ. Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination. Vaccine. 2007;25:3971-3979. (Pubitemid 46616994)
24. Giammanco MD, Coniglio MA, Pignato S, et al. An economic analysis of rotavirus vaccination in Italy. Vaccine. 2009;27:3904-3911.